213 related articles for article (PubMed ID: 7669730)
1. Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells.
Velcich A; Palumbo L; Jarry A; Laboisse C; Racevskis J; Augenlicht L
Cell Growth Differ; 1995 Jun; 6(6):749-57. PubMed ID: 7669730
[TBL] [Abstract][Full Text] [Related]
2. Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation.
Augenlicht L; Shi L; Mariadason J; Laboisse C; Velcich A
Oncogene; 2003 Aug; 22(32):4983-92. PubMed ID: 12902981
[TBL] [Abstract][Full Text] [Related]
3. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
4. Steady-state levels of mitochondrial messenger RNA species characterize a predominant pathway culminating in apoptosis and shedding of HT29 human colonic carcinoma cells.
Heerdt BG; Houston MA; Rediske JJ; Augenlicht LH
Cell Growth Differ; 1996 Jan; 7(1):101-06. PubMed ID: 8788038
[TBL] [Abstract][Full Text] [Related]
5. Alteration in expression of MUC2 and MUC3 mRNA levels in HT29 colonic carcinoma cells.
Mack DR; Hollingsworth MA
Biochem Biophys Res Commun; 1994 Mar; 199(2):1012-8. PubMed ID: 8135773
[TBL] [Abstract][Full Text] [Related]
6. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
Yang GY; Shamsuddin AM
Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
[TBL] [Abstract][Full Text] [Related]
7. Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells.
Schroy PC; Rustgi AK; Ikonomu E; Liu XP; Polito J; Andry C; O'Keane JC
J Cell Physiol; 1994 Oct; 161(1):111-23. PubMed ID: 7929596
[TBL] [Abstract][Full Text] [Related]
8. Effect of sodium butyrate on the expression of retinoblastoma (RB1) and P53 gene and phosphorylation of retinoblastoma protein in human colon tumor cell line HT29.
Gope R; Gope ML
Cell Mol Biol (Noisy-le-grand); 1993 Sep; 39(6):589-97. PubMed ID: 8220069
[TBL] [Abstract][Full Text] [Related]
9. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose.
Gaudier E; Jarry A; Blottière HM; de Coppet P; Buisine MP; Aubert JP; Laboisse C; Cherbut C; Hoebler C
Am J Physiol Gastrointest Liver Physiol; 2004 Dec; 287(6):G1168-74. PubMed ID: 15308471
[TBL] [Abstract][Full Text] [Related]
10. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene.
Velcich A; Corner G; Palumbo L; Augenlicht L
Oncogene; 1999 Apr; 18(16):2599-606. PubMed ID: 10353603
[TBL] [Abstract][Full Text] [Related]
11. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells.
Barnard JA; Warwick G
Cell Growth Differ; 1993 Jun; 4(6):495-501. PubMed ID: 8373733
[TBL] [Abstract][Full Text] [Related]
12. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS
J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrate.
Hay FG; Duncan LW; Langdon SP; Leonard RC
Br J Cancer Suppl; 1991 Jun; 14():33-5. PubMed ID: 1645568
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
[TBL] [Abstract][Full Text] [Related]
15. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
16. Phorbol 12-myristate 13-acetate induces alteration in mucin gene expression and biological properties of colon cancer cells.
Han SY; Lee MS; Kim HR; Baek SH; Ahn DH; Chae HS; Erickson RH; Sleisenger MH; Kim YS
Int J Oncol; 2000 Sep; 17(3):487-94. PubMed ID: 10938388
[TBL] [Abstract][Full Text] [Related]
17. Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells.
Guilbaud NF; Gas N; Dupont MA; Valette A
J Cell Physiol; 1990 Oct; 145(1):162-72. PubMed ID: 2211839
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.
Foss FM; Veillette A; Sartor O; Rosen N; Bolen JB
Oncogene Res; 1989; 5(1):13-23. PubMed ID: 2476706
[TBL] [Abstract][Full Text] [Related]
19. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
Ho SB; Ewing SL; Montgomery CK; Kim YS
Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775
[TBL] [Abstract][Full Text] [Related]
20. Expression and characterization of mucins associated with the resistance to methotrexate of human colonic adenocarcinoma cell line HT29.
Dahiya R; Lesuffleur T; Kwak KS; Byrd JC; Barbat A; Zweibaum A; Kim YS
Cancer Res; 1992 Sep; 52(17):4655-62. PubMed ID: 1511431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
